Krebs Biochemicals & Industries has informed that meeting of the Board of Directors of the Company will be held on Tuesday, May 21, 2024, to consider and adopt the Audited Financial Results for the 4th quarter and financial year ended 31st March, 2024. Further, with reference to the above meeting of the Board of Directors, it has informed vide its letter dated 21st March, 2024 that the trading window for dealing in the securities of the Company by the Insiders as defined under the SEBI (Prohibition of Insider Trading) Regulations, 2015 shall remain closed with effect from closure of business hours on 31st March, 2024 and until 48 hours after the declaration of the Company's audited financial results for the 4th quarter and financial year ended 31st March, 2024.
The above information is a part of company’s filings submitted to BSE.